Analysis and optimization of substitution treatment in Belgium. Conclusions and recommendations : summary

dc.contributor.author	Belspo
dc.date	2013
dc.date.accessioned	2016-06-13T11:35:58Z
dc.date.available	2016-06-13T11:35:58Z
dc.identifier.uri	https://orfeo.belnet.be/handle/internal/4178
dc.description	response to the emerging opiate use, opiate substitution treatment (OST) first appeared in the EU in the late 1960s (EMCDDA, 2000). Several international studies show that OST treatment is effective in reducing crime (Schwarts et al., 2009), reducing risks (Keen, Oliver, Rowse, & Mathers, 2003), reducing morbidity and mortality (Moller, Karymbaeva, Subata, Kiaer, 2009) reducing heroin use (Amato, Davolia, Peruccia, Ferria, Faggiano, & Mattick, 2005), reducing the use of other illegal drugs (Masson et al., 2004), increasing treatment retention (Amato et al., 2005) and increasing quality of life regarding employment, housing status and education (Vanagas, Padaiga, & Bagdonas, 2010).
dc.language	eng
dc.publisher	Brussels : Federal Science Policy, 2013
dc.title	Analysis and optimization of substitution treatment in Belgium. Conclusions and recommendations : summary
dc.type	Report
dc.subject.frascati	Health sciences
dc.subject.frascati	Clinical medicine
dc.audience	Policy-Oriented
dc.audience	Scientific
dc.subject.free	HEALTH
Orfeo.peerreviewed	Not pertinent
dc.identifier.belspo	SP2562
dc.relation.belspo-project	DR/58